Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Kuwata

Showing results (111-120 of 120) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 120 results.
Cardiovascular Research|December 1, 1996
Tyrosine kinase inhibitor suppresses the (re) stenotic changes of the coronary artery after balloon injury in pigsY Fukumoto, H Shimokawa, T Kozai, et al.
Circulation|January 7, 1998
Enhanced myosin light chain phosphorylations as a central mechanism for coronary artery spasm in a swine model with interleukin-1betaN Katsumata, H Shimokawa, M Seto, et al.
British Journal of Cancer|January 14, 2012
Combined effect of ALK and MEK inhibitors in EML4-ALK-positive non-small-cell lung cancer cellsJ Tanizaki, I Okamoto, K Takezawa, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|October 1, 1982
[Esophageal achalasia associated with superficial spreading type of early esophageal cancer--report of a case]S Tanaka, E Okamoto, K Kuwata, et al.
Journal of Cardiovascular Pharmacology|April 1, 1997
Tyrosine kinase inhibitor markedly suppresses the development of coronary lesions induced by long-term treatment with platelet-derived growth factor in pigs in vivoT Kozai, H Shimokawa, Y Fukumoto, et al.
Cardiovascular Research|January 1, 2000
Rho-kinase-mediated pathway induces enhanced myosin light chain phosphorylations in a swine model of coronary artery spasmH Shimokawa, M Seto, N Katsumata, et al.
British Journal of Cancer|June 3, 2010
Marked anti-tumour activity of the combination of YM155, a novel survivin suppressant, and platinum-based drugsT Iwasa, I Okamoto, K Takezawa, et al.
Pediatric Research|March 3, 2001
Evaluation of accumulated mucopolysaccharides in the brain of patients with mucopolysaccharidoses by (1)H-magnetic resonance spectroscopy before and after bone marrow transplantationY Takahashi, K Sukegawa, M Aoki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 2, 1998
[Correlation between pyrimidine nucleoside phosphorylase (PyNPase)/platelet-derived endothelial cell growth factor and histological prognostic factor, and influences of 5'-deoxy-5-fluorouridine (5'-DFUR) administration on PyNPase levels. 5'-DFUR Joint Research Group in the Osaka Area for Gastric Cancer]Y Yamasaki, K Kuwata, K Hioki, et al.
Physical Review Letters|March 14, 2025
First Measurement of Missing Energy due to Nuclear Effects in Monoenergetic Neutrino Charged-Current InteractionsE Marzec, S Ajimura, A Antonakis, et al.
Pageof 12

Showing results (111-120 of 120) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
Cardiovascular Research|December 1, 1996
Tyrosine kinase inhibitor suppresses the (re) stenotic changes of the coronary artery after balloon injury in pigsY Fukumoto, H Shimokawa, T Kozai, et al.
Circulation|January 7, 1998
Enhanced myosin light chain phosphorylations as a central mechanism for coronary artery spasm in a swine model with interleukin-1betaN Katsumata, H Shimokawa, M Seto, et al.
British Journal of Cancer|January 14, 2012
Combined effect of ALK and MEK inhibitors in EML4-ALK-positive non-small-cell lung cancer cellsJ Tanizaki, I Okamoto, K Takezawa, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|October 1, 1982
[Esophageal achalasia associated with superficial spreading type of early esophageal cancer--report of a case]S Tanaka, E Okamoto, K Kuwata, et al.
Journal of Cardiovascular Pharmacology|April 1, 1997
Tyrosine kinase inhibitor markedly suppresses the development of coronary lesions induced by long-term treatment with platelet-derived growth factor in pigs in vivoT Kozai, H Shimokawa, Y Fukumoto, et al.
Cardiovascular Research|January 1, 2000
Rho-kinase-mediated pathway induces enhanced myosin light chain phosphorylations in a swine model of coronary artery spasmH Shimokawa, M Seto, N Katsumata, et al.
British Journal of Cancer|June 3, 2010
Marked anti-tumour activity of the combination of YM155, a novel survivin suppressant, and platinum-based drugsT Iwasa, I Okamoto, K Takezawa, et al.
Pediatric Research|March 3, 2001
Evaluation of accumulated mucopolysaccharides in the brain of patients with mucopolysaccharidoses by (1)H-magnetic resonance spectroscopy before and after bone marrow transplantationY Takahashi, K Sukegawa, M Aoki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 2, 1998
[Correlation between pyrimidine nucleoside phosphorylase (PyNPase)/platelet-derived endothelial cell growth factor and histological prognostic factor, and influences of 5'-deoxy-5-fluorouridine (5'-DFUR) administration on PyNPase levels. 5'-DFUR Joint Research Group in the Osaka Area for Gastric Cancer]Y Yamasaki, K Kuwata, K Hioki, et al.
Physical Review Letters|March 14, 2025
First Measurement of Missing Energy due to Nuclear Effects in Monoenergetic Neutrino Charged-Current InteractionsE Marzec, S Ajimura, A Antonakis, et al.
Pageof 12